![](https://media.bulios.com/media/ticker/cd5f8c9b-c305-4238-945b-eb2f868a0adc.png?w=100&h=100&mode=crop)
Novo Nordisk
NVO
NVO Fair Price
![](https://media.bulios.com/media/ticker/cd5f8c9b-c305-4238-945b-eb2f868a0adc.png?w=100&h=100&mode=crop)
My Notes
Začít psátFeed
Analysts at Berenberg have raised their estimates for the global obesity market to $150 billion by 2035, up from $125 billion previously. This revision is the result of positive data on co-morbidities and advances in competing studies. Berenberg recommends buying shares of $LLY-2.0% and Zealand Pharma, while he recommends holding on to shares of $NVO-0.9%.
What are your...
Read more
📊 Investment Calendar 📆
Earnings season is in full swing, and with it comes more exciting news. Here is a summary of the news I will be following.
Monday: I'll only be watching company results.
📈 Earnings: Before the markets open, I'll be watching Domino's Pizza $DPZ, SoFi Technologies $SOFI+1.9% and ON Semiconductor $ON+3.9%. After the close, just the results of Paramount $PARA...
Read more
📈💡 New and interesting player on the pharmaceutical market! 💊🔍
One of the most discussed topics in the pharmaceutical market is the treatment of obesity and diabetes. Only two companies are behind many successful drugs such asOzempic, Rybelsus and Saxenda: Novo Nordisk $NVO and Eli Lilly $LLY. These companies have had significant success in the treatment of diabetes and...
Read more
![](https://media.bulios.com/media/avatars/b268453b-69ee-46f4-b405-83a8318f9e69.jpeg?w=100&h=100&mode=crop&crop=faces)
Novo Nordisk A/S is a Danish company that recently introduced a cure for obesity. Shares of $NVO-0.9% are up more than 20% in the past month and more than 40% this year. For me, the company is going in a good direction and the business is also great, as obesity is really affecting a lot of people at the moment and if the development of this drug goes as well in the future as it...
Read more
Zobrazit další komentáře
![](https://media.bulios.com/media/avatars/efa446e6-6c7a-44c8-9c5a-e7f756964f08.png?w=100&h=100&mode=crop&crop=faces)
The company is doing very well indeed. It's healthy and making solid amounts of money. The chart is logically consistent with that. But now I think it's way up and even though there's no major tooth on the chart, I'm not going to go for it.
Novo Nordisk $NVO-0.9% closed the day yesterday with a larger market capitalisation than LVMH, making it Europe's largest public company. Novo's share price rose 1.9 percent to $189.3, giving the company a market capitalization of $423 billion.
Do you have shares of $NVO in your portfolio?
![NVO](https://media.bulios.com/media/ticker/cd5f8c9b-c305-4238-945b-eb2f868a0adc.png)
Novo Nordisk
NVOZobrazit další komentáře
![](https://media.bulios.com/media/avatars/b268453b-69ee-46f4-b405-83a8318f9e69.jpeg?w=100&h=100&mode=crop&crop=faces)
I don't have NVO stock in my portfolio, but I am very interested in the company and have been following it from afar :)
Have a nice Sunday, what are your views on Novo Nordisk $NVO-0.9% farm ? Thursday's results were very good and the company is obviously doing very well right now :)
![NVO](https://media.bulios.com/media/ticker/cd5f8c9b-c305-4238-945b-eb2f868a0adc.png)
Novo Nordisk
NVOZobrazit další komentáře
![](https://media.bulios.com/media/avatars/4c53bdc6-4799-4ff9-91c3-90a26d020d81.png?w=100&h=100&mode=crop&crop=faces)
The company looks great to me, but the price? Ugh... I don't know if I'd enter.
This sector currently has great potential. However, shares in this sector are already quite expensive. I bought $NVO-0.9% and I don't regret it.